The Zhitong Finance App learned that Morgan Stanley said that the announcement reached between AstraZeneca (AZN.US) and the US government on tariffs and drug pricing may bring relief and push for further improvement in industry sentiment. The bank gave AstraZeneca an an “gain” rating, with a target price of £137.

Zhitongcaijing · 10/14 09:17
The Zhitong Finance App learned that Morgan Stanley said that the announcement reached between AstraZeneca (AZN.US) and the US government on tariffs and drug pricing may bring relief and push for further improvement in industry sentiment. The bank gave AstraZeneca an an “gain” rating, with a target price of £137.